Breaking News

Charles River, Metabolon in Biomarker Partnership

Will offer biomarker identification services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Charles River Discovery Services has entered into an oncology biomarker research collaboration with Metabolon. The partnership combines Charles River’s preclinical oncology study expertise with Metabolon’s analysis of metabolic data to identify both mechanism of action and biomarkers. Metabolon’s customized Metabolomics platform allows for quick validation of ideas and biomarker identification of mechanism of action. Together the companies will provide: elucidation, identification, characteriza...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters